Aisling Capital LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 62 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Aisling Capital LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$11,633,000
+25.2%
482,6800.0%1.99%
+17.7%
Q1 2017$9,292,000
+25.0%
482,6800.0%1.69%
-2.1%
Q4 2016$7,433,000
+18.4%
482,6800.0%1.73%
+33.5%
Q3 2016$6,280,000
-6.5%
482,6800.0%1.29%
-18.4%
Q2 2016$6,714,000
-35.2%
482,680
-29.3%
1.59%
-23.5%
Q1 2016$10,356,000
-20.0%
682,6800.0%2.07%
-7.1%
Q4 2015$12,950,000
-0.2%
682,6800.0%2.23%
-2.1%
Q3 2015$12,971,000
-26.3%
682,6800.0%2.28%
-13.0%
Q2 2015$17,593,000
-17.6%
682,6800.0%2.62%
-6.2%
Q1 2015$21,341,000
-18.9%
682,6800.0%2.79%
-30.0%
Q4 2014$26,317,000682,6803.99%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders